Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's After-Market Session

Author: Benzinga Insights | January 12, 2024 05:31pm

Gainers

  • Aclarion (NASDAQ:ACON) stock rose 21.6% to $3.82 during Friday's after-market session. The company's market cap stands at $3.2 million.
  • Outset Medical (NASDAQ:OM) shares rose 10.61% to $4.95. The market value of their outstanding shares is at $248.5 million.
  • Absci (NASDAQ:ABSI) stock moved upwards by 9.77% to $4.38. The market value of their outstanding shares is at $407.0 million.
  • Processa Pharma (NASDAQ:PCSA) shares rose 8.71% to $0.29. The company's market cap stands at $7.0 million.
  • Cara Therapeutics (NASDAQ:CARA) stock increased by 7.94% to $0.62. The company's market cap stands at $33.5 million.
  • Monopar Therapeutics (NASDAQ:MNPR) shares moved upwards by 6.44% to $0.46. The market value of their outstanding shares is at $6.8 million.

Losers

  • Atreca (NASDAQ:BCEL) stock decreased by 21.4% to $0.28 during Friday's after-market session. The market value of their outstanding shares is at $11.0 million.
  • Estrella Immunopharma (NASDAQ:ESLA) shares declined by 10.57% to $1.1. The market value of their outstanding shares is at $38.7 million.
  • Nektar Therapeutics (NASDAQ:NKTR) stock declined by 6.41% to $0.5. The market value of their outstanding shares is at $95.3 million.
  • Brainstorm Cell (NASDAQ:BCLI) shares decreased by 5.17% to $0.31. The company's market cap stands at $15.1 million.
  • Context Therapeutics (NASDAQ:CNTX) shares fell 5.05% to $1.13. The company's market cap stands at $18.0 million.
  • Revelation Biosciences (NASDAQ:REVB) shares fell 5.03% to $0.45. The company's market cap stands at $2.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ABSI ACON BCEL BCLI CARA CNTX ESLA MNPR NKTR OM PCSA REVB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist